BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25395320)

  • 1. Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models.
    Gad E; Rastetter L; Slota M; Koehnlein M; Treuting PM; Dang Y; Stanton S; Disis ML
    Breast Cancer Res Treat; 2014 Dec; 148(3):501-10. PubMed ID: 25395320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent.
    Phan-Lai V; Dang Y; Gad E; Childs J; Disis ML
    Clin Cancer Res; 2016 May; 22(9):2207-16. PubMed ID: 26660518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.
    Estrela-Lima A; Araújo MS; Costa-Neto JM; Teixeira-Carvalho A; Barrouin-Melo SM; Cardoso SV; Martins-Filho OA; Serakides R; Cassali GD
    BMC Cancer; 2010 Jun; 10():256. PubMed ID: 20525350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
    Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
    Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone promotes immunomodulation and tumor development in the murine mammary gland.
    Werner LR; Gibson KA; Goodman ML; Helm DE; Walter KR; Holloran SM; Trinca GM; Hastings RC; Yang HH; Hu Y; Wei J; Lei G; Yang XY; Madan R; Molinolo AA; Markiewicz MA; Chalise P; Axelrod ML; Balko JM; Hunter KW; Hartman ZC; Lange CA; Hagan CR
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33958486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
    Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
    Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for T-lymphocytes in human breast cancer and in canine mammary tumors.
    Carvalho MI; Pires I; Prada J; Queiroga FL
    Biomed Res Int; 2014; 2014():130894. PubMed ID: 24672781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer.
    Karkeni E; Morin SO; Bou Tayeh B; Goubard A; Josselin E; Castellano R; Fauriat C; Guittard G; Olive D; Nunès JA
    Front Immunol; 2019; 10():1307. PubMed ID: 31244851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
    Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
    Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer.
    Hahn T; Alvarez I; Kobie JJ; Ramanathapuram L; Dial S; Fulton A; Besselsen D; Walker E; Akporiaye ET
    Int J Cancer; 2006 May; 118(9):2220-31. PubMed ID: 16331615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
    Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
    Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
    Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
    Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.
    Blanco-Aparicio C; Pérez-Gallego L; Pequeño B; Leal JF; Renner O; Carnero A
    Carcinogenesis; 2007 Mar; 28(3):584-94. PubMed ID: 17050554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.